A Masculine-Presenting Female Adolescent: a Rare Case of Poorly-Differentiated Sertoli-Leydig Cell Tumor

Sarah Abigail  N. Manalang,; Darlene Minette  Zamora,; Judith  G. Cabanela,

A Masculine-Presenting Female Adolescent: a Rare Case of Poorly-Differentiated Sertoli-Leydig Cell Tumor

Sarah Abigail N. Manalang | Judith G. Cabanela | Darlene Minette Zamora

Abstract:

Virilization is characterized as females presenting with masculine features which include amenorrhea, oligomenorrhea, hirsutism, severe acne, clitoromegaly, breast atrophy and deepening of the voice. The probable causes of virilization in the young are adrenocortical and gonadal tumors. Sertoli-Leydig cell tumor (SLCT), also known as androblastoma, is a gonadal tumor belonging to the group of mixed sex cord - stromal tumors. This occurs in less than 0.5% of the population and presents with virilization in at least one-third of its cases. Symptoms at presentation depend on either excess of hormones or a mass-occupying lesion. The objectives of this clinical case report are to present a rare case of SLCT in an adolescent female and to discuss its diagnosis and management. We present a case of a 15-year-old nulligravid who consulted for abdominal enlargement associated with oligomenorrhea, multiple acne, hirsutism and deepening of the voice. Physical examination showed clitoromegaly and a 17x10cm abdominal mass. Transrectal sonography revealed an ovarian new growth containing both solid and cystic components with non-benign sonomorphologic features, a color score of 2, and massive ascites. Tumor markers revealed elevated levels of CA-125 and testosterone. Left salpingo-oophorectomy with peritoneal fluid cytology, bilateral lymph node dissection, infracolic omentectomy, and resection of retroperitoneal implants were done. Histopathologic report showed poorly differentiated SLCT, Stage IIIC. Chemotherapy was administered but was not completed. SLCT must always be considered in young female patients presenting with symptoms of virilization and ovarian mass for proper diagnoses and management.

References:

Santi M, Graf S, Zeino M, Cools M, Van De Vijer KV, Trippel M, et al. Approach to the Virilizing Girl at Puberty. The Journal of Clinical Endocrinology and Metabolism. 2021; 106 (5): 1530 - 1539.
Abu-Zaid A, Azzam A, Alghuneim LA, Metawee MT, Amin T, and Al-Hussain TO. Poorly Differentiated Ovarian Sertoli-Leydig Cell Tumor in a 16-Year-Old Single Woman: A Case Report and Literature Review. Case Report in Obstetrics and Gynecology (Hindawi). 2013: 1 - 6.
Yoost J, Savage A. Screening and Management of the Hyperandrogenic Adolescent. American College of Obstetricians and Gynecologists (ACOG) Committee Opinion Number 789. 2019; 134 (4): e106 – e114.
Pugeat M, Plotton I, de la Perrière AB, Raverot G, Dèchaud H, Raverot V. Hyperandrogenic states in women: pitfalls in laboratory diagnosis. European Journal of Endocrinology. 2018; 178 (4): R141 – R154.
Gershenson DM. Sex cord-stomal tumors of the ovary: Epidemiology, clinical features, and diagnosis in adults. UpToDate. September 2021. Retrieved October 25, 2021 from https://bit.ly/34cDhLY
Harbi RA, Mcneish IA, El-Bahrawy M. Ovarian sex cord-stromal tumors: an update on clinical features, molecular changes, and management. International Journal of Gynecological Cancer. 2021; 31: 161 – 168.
Xu Q, Zou Y, and Zhang XF. Sertoli-Leydig cell tumors of ovary - A case series. Wolters Kluwer Health Inc. 2018; 97 (42): 1 - 9.
Gupta MM, Bahri NU, Ketan R. Sertoli-Leydig Cell Tumor of the Ovary in a Young Female: A Case Report and Literature Review. Saudi Journal of Medicine and Medical Sciences. 2015; 3 (3): 233 – 237.
Ilagan, MK, Pacheco EP, Totesora DZ, Chua LR, Jalique JR. The Modified Ferriman-Gallwey Score and Hirsutism among Filipino Women. Endocrinology and Metabolism (Seoul). 2019; 34 (4): 374 – 381.
Gupta M, Saini V, Poddar A, Kumari S, Maitra A. Acquired Clitoromegaly: A Gynaecological Problem or an Obstetric Complication? Journal of Clinical and Diagnostic Research. 2016; 10 (12): 10 – 11.
Sahoo TK, Samal S, Dhal I, Majumdar SK, Parida DK. Sertoli-Leydig Cell Tumor of Ovary, Management and Prognosis: A Review of Literature. International Journal of Scientific Study. 2017; 4 (10): 164 – 167.
Chen J, Liu Y, Zhang Y, Wang Y, Chen X, Wang Z. Imaging, clinical and pathologic findings of Sertoli-Leydig Cell Tumors. Science Progress (SAGE). 2021; 104 (2): 1 – 10.
Billod JA, Wylengco MC, Mata-Carillo DG, Yap BC, Parroco MI. Ovarian, Fallopian, and Peritoneal Cancer. In: SGOP Clinical Practice Guidelines for the Obstetrician-Gynecologist (Third Edition). OVT-Graphic Line, Inc. Printing and Publishing House. p. 76 – 96.
Cai SQ, Zhao SH, Qiang JW, Zhang GF, Wang XZ, Wang L. Ovarian Sertoli-Leydig Cell Tumors: MRI Findings and Pathological Correlation. Journal of Ovarian Research. 2013; 6 (73): 1 – 5.
Dhanya R, Padhi S, Varghese RG. Sertoli-Leydig Cell Tumor of Ovary – A Diagnostic Dilemma. Journal of Clinical and Diagnostic Research. 2014; 8 (3): 127 – 129.
Buza N. Ovary – Sex cord stromal tumors (Sertoli-Leydig Cell Tumor). Pathology Outlines. 2021 [cited 2022 January 29]. Available from: https://www.pathologyoutlines.com/topic/ovar ytumorsertolileydig.html
Gerhenson DM. Sex cord-stromal tumors of the ovary: Management in adults. UpToDate. September 2021. Retrieved January 30, 2022 from https://rb.gy/ipiluw
Seidler SJ, Huber A, Nef J, and Huber DE. Sertoli-Leydig Cell Ovarian Tumors: Is Fertility or Endocrine-Sparing Surgery an Option upon Relapse? Case Reports in Oncology. 2020; 13: 935 - 940.
San Juan F, Toral JA. Ovarian, Fallopian Tube, and Primary Peritoneal Cancers. In: Society of Gynecologic Oncologists of the Philippines (Foundation), Inc. - Clinical Practice Guidelines (8th Edition). OVT-Graphic Line, Inc. Printing and Publishing House. p. 64 – 85.
Sigismondi C, Gadducci A, Lorusso D, Candiani M, Breda E, Raspagliesi F, et al. Ovarian Sertoli-Leydig Cell Tumors. A Retrospective MITO Study. Gyencol Oncol. 2012; 125 (3): 673 – 676.